In just a few short months, Marathon has minted a highly quotable line: “Escape will make me God.” It’s also, according to ...

Mathematics is filled with conjectures that involve infinite recursive structure, representing complex structures and underlying deep relationships. Discovering such conjectures is crucial for ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Nvidia sold its entire 7.71 million share stake in Recursion Pharmaceuticals by December 31, 2025 Recursion stock swung 14% lower intraday Wednesday before closing 2% higher ARK Invest bought 1.25 ...

A few stanzas from the end of Chaucer’s long poem “Troilus and Criseyde,” the author interrupts his story to indulge in a bit of reception anxiety. “Go, litel book,” he bids the manuscript that’s soon ...

With the new season underway, there’s certainly a lot of content to play or watch in League of Legends. While most of the season is all about Summoner’s Rift, Riot did confirm that ARAM Mayhem is ...

Noah, the world's strongest six-year-old, holds the fortunate position of being the Thirteenth Prince of the emperor. Born with an infinite level cap and a cheat skill that allows him to add the ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...